Endocrinology, Vol 136, 3759-3766, Copyright © 1995 by Endocrine Society

ARTICLES

Insulin-like growth factors (IGFs) stimulate the release of alpha 1- antichymotrypsin and soluble IGF-II/mannose 6-phosphate receptor from MCF7 breast cancer cells

C Confort, H Rochefort and F Vignon
INSERM, Unit 148 on Hormones and Cancer, Montpellier, France.

The growth of hormone-responsive MCF7 human breast cancer cells is controlled by steroid hormones and growth factors. By metabolic labeling of cells grown in steroid- and growth factor-stripped serum conditions, we show that insulin-like growth factors (IGF-I and IGF-II) increase by approximately 5-fold the release of several proteins including cathepsin D, alpha 1-antichymotrypsin, and soluble forms of the multifunctional IGF-II/mannose 6-phosphate (M6P) receptor. Two soluble forms of IGF-II/M6P receptors were detected, one major (approximately 260 kilodaltons) and one minor (approximately 85 kilodaltons) that probably represents a proteolytic fragment of the larger soluble molecule. IGFs increased receptor release in a dose- dependent fashion with 50-60% of newly synthesized receptor released at 5-10 nM IGFs. The release of IGF-II/M6P receptors correlated with the levels of secreted cathepsin D in different human breast cancer cells or in rats stable transfectants that are constitutively expressing variable levels of human cathepsin D. IGFs had a stronger effect on IGF- II/M6P receptor release, whereas estradiol treatment preferentially enhanced the release of protease and antiprotease. We thus demonstrate that in human breast cancer cells, IGFs not only act as strong mitogens but also regulate release of alpha 1-antichymotrypsin, IGF-II/M6P- soluble receptor, and cathepsin D; three proteins that potentially regulate cell proliferation and/or invasion.

This article has been cited by other articles:

				Z. Yang, L. E. Harris, D. E. Palmer-Toy, and W. S. Hancock Multilectin Affinity Chromatography for Characterization of Multiple Glycoprotein Biomarker Candidates in Serum from Breast Cancer Patients Clin. Chem., October 1, 2006; 52(10): 1897 - 1905. [Abstract] [Full Text] [PDF]

				C. F. Singer, M. Mogg, W. Koestler, M. Pacher, E. Marton, E. Kubista, and M. Schreiber Insulin-Like Growth Factor (IGF)-I and IGF-II Serum Concentrations in Patients with Benign and Malignant Breast Lesions: Free IGF-II Is Correlated with Breast Cancer Size Clin. Cancer Res., June 15, 2004; 10(12): 4003 - 4009. [Abstract] [Full Text] [PDF]

				J.-i. Satoh, Y. Kuroda, and S. Katamine Gene Expression Profile in Prion Protein-Deficient Fibroblasts in Culture Am. J. Pathol., July 1, 2000; 157(1): 59 - 68. [Abstract] [Full Text] [PDF]

				K. El Messaoudi, L. F. Thiry, C. Liesnard, N. Van Tieghem, A. Bollen, and N. Moguilevsky A Human Milk Factor Susceptible to Cathepsin D Inhibitors Enhances Human Immunodeficiency Virus Type 1 Infectivity and Allows Virus Entry into a Mammary Epithelial Cell Line J. Virol., January 1, 2000; 74(2): 1004 - 1007. [Abstract] [Full Text]

				M. Costello, R. C. Baxter, and C. D. Scott Regulation of Soluble Insulin-Like Growth Factor II/Mannose 6-Phosphate Receptor in Human Serum: Measurement by Enzyme-Linked Immunosorbent Assay J. Clin. Endocrinol. Metab., February 1, 1999; 84(2): 611 - 617. [Abstract] [Full Text]

				W. Xing and T. K. Archer Upstream Stimulatory Factors Mediate Estrogen Receptor Activation of the Cathepsin D Promoter Mol. Endocrinol., September 1, 1998; 12(9): 1310 - 1321. [Abstract] [Full Text]

				V Laurent-Matha, M. Farnoud, A Lucas, C Rougeot, M Garcia, and H Rochefort Endocytosis of pro-cathepsin D into breast cancer cells is mostly independent of mannose-6-phosphate receptors J. Cell Sci., January 9, 1998; 111(17): 2539 - 2549. [Abstract] [PDF]